Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnostic and clinical significance of Crohn's disease-specific pancreatic anti-GP2 and anti-CUZD1 antibodies.

Clinical chemistry and laboratory medicine - 1 Feb 2016

Pavlidis Polychronis, Komorowski Lars, Teegen Bianca, Liaskos Christos, Koutsoumpas Andreas L, Smyk Daniel S, Perricone Carlo, Mytilinaiou Maria G, Stocker Winfried, Forbes Alastair, Bogdanos Dimitrios P

Abstract excerpt

BACKGROUND: Pancreatic autoantibodies (PAB) targeting GP2 and CUZD1 are Crohn's disease (CrD)-markers. The clinical significance of anti-GP2 antibodies has been assessed, but that of anti-CUZD1 remains elusive. The aim of the study was to assess the clinical utility of anti-CUZD1/anti-GP2 by novel cell-based indirect immunofluorescence (IIF) assays in CrD. METHODS: A total of 212 CrD and 249 UC patients followed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies
Share to Autoantibodies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colitis, Ulcerative

Share to Crohn Disease

Share to HEK293 Cells

Share to Immunoglobulin A

Share to Immunoglobulin G

Share to Membrane Glycoproteins

Source

Identifiers

PMID: 26351932
DOI: 10.1515/cclm-2015-0376

Genes

CUZD1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Diagnostic and clinical significance of Crohn's disease-specific pancreatic anti-GP2 and anti-CUZD1 antibodies.PMID 26351932Read ↗

Pancreatic Autoantibodies Against CUZD1 and GP2 Are Associated with Distinct Clinical Phenotypes of Crohn's Disease.Semantic proximity Read ↗

Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn’s Patients: The Importance of Specific Target Antigens [GP2 and CUZD1]Semantic proximity Read ↗

Pancreatic autoantibodies in inflammatory bowel disease.Semantic proximity Read ↗

Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort.Semantic proximity Read ↗

Autoantibodies Against Glycoprotein 2 Isoforms in Pediatric Patients with Inflammatory Bowel Disease.Semantic proximity Read ↗

Serological studies in inflammatory bowel disease: how important are they?Semantic proximity Read ↗

Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression.Semantic proximity Read ↗

Dietary antigens in Crohn's disease: antibodies to porcine pancreatic amylase.Semantic proximity Read ↗

Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations.Semantic proximity Read ↗

Phenotypic associations of Crohn's disease with antibodies to flagellins A4-Fla2 and Fla-X, ASCA, p-ANCA, PAB, and NOD2 mutations in a Swiss Cohort.Semantic proximity Read ↗

Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.